MCG Heart Scan: The Complete Guide

The MCG heart scan, short for multifunction cardiogram, is an FDA-cleared heart test that analyzes the heart's electrical signals at rest to look for early signs of reduced blood flow and heart dysfunction. It belongs to the field of noninvasive cardiac screening, alongside the resting EKG, the stress test and coronary calcium scoring. Heart disease is the top cause of death in the United States, and cardiovascular disease caused 919,032 deaths in 2023, about 1 in every 3, according to the CDC. The MCG adds a radiation-free look at how the heart functions before symptoms appear. The MCG Heart Scan at Wellness Architecture in Menlo Park takes about 10 minutes and needs no referral.

How the MCG Heart Scan Works

The MCG heart scan records the heart's electrical activity at rest and turns it into a scored report. The process follows five steps:

1. Lead placement. A technician places clamps on both wrists and ankles and one adhesive electrode on the left side of the ribcage. Clothing stays on.
2. Recording. The patient lies still while the device records five tracings of 82 seconds each, just under seven minutes in total.
3. Upload. The tracings travel to a secure central server for analysis.
4. Database comparison. Software analyzes the signal patterns and compares them with a large database of validated cases.
5. Scored report. A report returns with scores that a clinician interprets and reviews with the patient.

No fasting is needed. Lotions and oils interfere with the leads, and a belt, watch and bracelets come off before the scan. At Wellness Architecture, the written report arrives within a few days, and a results review with Dr. Samia McCully follows a few days to a week after the scan.

What the MCG Measures

The MCG measures functional and electrical changes in the heart rather than its physical structure. According to the manufacturer, the scan looks for four patterns:

• Silent ischemia, meaning reduced blood flow to the heart muscle without chest pain or other symptoms.
• Small-vessel and microvascular problems, in the tiny coronary vessels that angiograms and calcium scans do not show.
• Metabolic and autonomic stress on the heart, reflecting strain from blood sugar problems, high blood pressure and nervous system imbalance.
• Dysregulation that comes before structural damage, the functional shift that precedes plaque or scarring.

The report flags these patterns for clinical follow-up; it does not diagnose a specific disease on its own. Abnormal findings lead to a conversation about cardiology referral, further testing and risk-factor treatment.

Heart Tests Compared

Heart tests answer different questions, so no single test gives the full picture. The table compares the most common options:

The 2018 ACC/AHA cholesterol guideline recommends a calcium score for adults at intermediate 10-year risk, 7.5 to 20 percent, when the decision about statin therapy remains uncertain. A calcium score of zero in that group supports delaying statins in many cases.

Who Considers an MCG Heart Scan

An MCG heart scan suits adults who want an early look at heart function before symptoms. Five groups consider it most often:

1. Women after menopause, when heart risk climbs as estrogen falls.
2. People with high blood pressure, prediabetes, diabetes or insulin resistance, which strain the heart for years before symptoms.
3. People with a family history of heart disease.
4. Active adults who want more than a routine physical.
5. Anyone wanting a baseline to track over time.

Chest pain, pressure or shortness of breath right now calls for 911 or an emergency room, not a screening scan. The MCG Heart Scan at Wellness Architecture is open to adults whether or not they are current patients, and it is HSA and FSA eligible.

Dr. McCully's interest is personal. Her father died at 60 of an aortic aneurysm and her grandmother at 84 of a brain aneurysm. She describes receiving a D on her own first MCG scan, then a B five weeks later after changing her diet, losing weight and stopping caffeine. That is one person's experience, not a predictable outcome.

Blood Markers That Complete the Heart Picture

Blood markers measure the chemical risk factors that a scan does not see, so the two work together. Dr. McCully's heart-related markers include:

• A lipid panel, read for the triglyceride-to-HDL ratio. She treats a ratio above 2 as a sign of raised risk.
• ApoB, a count of the particles that carry cholesterol into artery walls.
• Lp(a), a largely inherited particle. The National Lipid Association's 2024 update recommends measuring it at least once in every adult, with levels below 75 nmol/L low risk and 125 nmol/L or higher high risk.
• Homocysteine, which she orders for every patient and aims to keep at 7 µmol/L or less, well below laboratory cutoffs of about 15.
• hs-CRP, oxidized LDL and fibrinogen, markers of inflammation and clotting tendency on Wellness Architecture's 20-marker Custom Wellness Panel.

Fasting insulin and A1C round out the picture, since blood sugar problems strain the heart long before diabetes appears. Dr. McCully describes the metabolic conditions she treats every day, from blood sugar and thyroid to inflammation, as trickling down into cardiovascular disease, so heart screening extends her root-cause work. The blood sugar and energy guide covers the metabolic side.

Heart Disease Often Develops Without Symptoms

Heart disease builds for years before chest pain or breathlessness appears. Someone in the United States has a heart attack every 40 seconds, about 805,000 a year, and about 1 in 5 of those heart attacks is silent, according to the CDC. Plaque, stiffening arteries and small-vessel damage progress quietly. Screening aims to find these changes while lifestyle and medical treatment still change the outcome.

Normal Cholesterol Does Not Rule Out Heart Disease

Normal cholesterol lowers risk but does not remove it. In a national registry of 136,905 hospitalizations for coronary artery disease, almost half of patients had an admission LDL cholesterol below 100 mg/dL (Sachdeva and colleagues, American Heart Journal, 2009). High blood pressure, insulin resistance, inflammation, Lp(a), smoking and family history all raise risk independently. A complete picture combines blood markers, blood pressure, metabolic health and functional testing.

Menopause Accelerates Heart Risk in Women

Cardiovascular risk rises during and after the menopause transition. A 2020 American Heart Association scientific statement describes changes in hormones, body fat distribution, lipids and blood vessel function during the transition that raise later heart disease risk, and identifies midlife as a window for early prevention. Heart disease caused 304,970 deaths among U.S. women in 2023, about 1 in 5 female deaths. The perimenopause and menopause guide covers the transition in full.

Small-Vessel Disease Hides From Standard Tests

Coronary microvascular dysfunction affects the tiny vessels that feed the heart muscle, and it is common in women with chest symptoms but open major arteries. In one cohort of the NHLBI-sponsored Women's Ischemia Syndrome Evaluation, 62 percent of women with signs of ischemia had no obstructive coronary disease. Angiograms and calcium scans image the large arteries, so they miss this pattern. Functional tests look at how the heart behaves rather than how the arteries look.

A Screening Result Starts a Plan Rather Than a Diagnosis

A screening scan sorts people toward next steps; it does not deliver a final diagnosis. A normal MCG offers a baseline to repeat over time. An abnormal result leads to a results review, risk-factor treatment and, when indicated, referral to a cardiologist for confirmatory testing. The value lies in acting earlier on blood pressure, blood sugar, cholesterol and inflammation.

Frequently Asked Questions

What does an MCG heart scan detect?

According to the manufacturer, the MCG looks for silent ischemia, small-vessel and microvascular problems, metabolic and autonomic stress on the heart, and dysregulation that comes before structural damage. It analyzes the heart's electrical signals at rest and reports a scored result that a clinician reviews.

How is the MCG different from an EKG?

A standard EKG records the heart's rhythm and signs of existing damage. The MCG starts from a resting ECG recording but analyzes the signals mathematically and compares them with a database of validated cases, looking for functional changes such as reduced blood flow that a standard tracing does not show.

Is the MCG the same as a calcium score?

No. A coronary calcium score uses a CT scan to measure calcified plaque in the coronary arteries, which involves radiation. The MCG measures electrical and functional patterns at rest without radiation. The two answer different questions and sometimes complement each other.

How to prepare for an MCG heart scan?

Preparation for an MCG heart scan is simple. No fasting is needed. Skip lotions and oils on the skin, wear loose clothing, and remove a belt, watch and bracelets. During the scan, lying still, breathing normally and staying awake keep the recording clean.

Who benefits from an MCG heart scan?

An MCG heart scan suits adults who want an early look at heart function: women after menopause, people with high blood pressure, prediabetes or diabetes, those with a family history of heart disease, active adults, and anyone wanting a baseline to track. Chest pain needs emergency care, not a screening scan.

Common Misconceptions About Heart Screening

Misconception: A Normal EKG Means a Healthy Heart

A resting EKG captures rhythm and signs of past damage over a few seconds. It often looks normal in people with narrowed arteries or small-vessel disease. About 1 in 5 heart attacks is silent, according to the CDC, so a normal tracing does not rule out disease.

Misconception: Heart Disease Mainly Affects Men

Heart disease caused 304,970 deaths among U.S. women in 2023, about 1 in 5 female deaths, according to the CDC. Women more often have coronary microvascular dysfunction, which standard tests for blocked arteries miss.

Misconception: Normal Cholesterol Means Low Heart Risk

In a national registry of patients hospitalized with coronary artery disease, almost half had admission LDL cholesterol below 100 mg/dL. Blood pressure, blood sugar, inflammation, Lp(a) and family history all add risk independent of cholesterol.

Misconception: Heart Screening Requires Radiation or Exercise

Some heart tests use radiation or a treadmill, but not all. The MCG records the heart's signals at rest for several minutes, with no needles, radiation or exercise. Calcium scoring and nuclear stress tests involve radiation.

Misconception: A Screening Test Replaces a Cardiologist

A screening result points to the next step rather than delivering a final diagnosis. Abnormal MCG findings lead to follow-up with a cardiologist and further testing, and the MCG complements cardiology care rather than replacing it.

Ongoing Debates in Heart Screening

The strength of MCG evidence draws scrutiny. In a single-center study of 116 patients referred for coronary angiography, the MCG identified significant narrowing with 91 percent sensitivity and 87 percent specificity, compared with 85 percent and 14 percent for nuclear stress imaging in the same patients (Strobeck and colleagues, International Journal of Medical Sciences, 2011). Most MCG studies come from small, manufacturer-affiliated groups, and the test does not appear in ACC/AHA screening guidelines.

Screening adults at low risk divides experts. The U.S. Preventive Services Task Force recommends against resting or exercise ECG screening in asymptomatic low-risk adults, citing harms such as unnecessary procedures, and finds the evidence insufficient for adults at intermediate or high risk. Preventive and integrative clinicians argue that earlier functional information motivates earlier risk-factor treatment.

Calcium scoring and functional testing compete for the preventive role. The calcium score has guideline support for statin decisions in intermediate-risk adults. Functional tests detect small-vessel problems that calcium scans miss, but with a thinner evidence base.

Homocysteine as a treatment target remains contested. A Cochrane review of B-vitamin trials found no reduction in heart attacks or deaths and a small reduction in stroke. Dr. McCully treats elevated homocysteine as a modifiable risk she does not leave untreated.

Universal Lp(a) testing gains ground. The National Lipid Association now recommends measuring Lp(a) at least once in every adult. Others note that targeted Lp(a)-lowering therapies are still under study, which limits what a high result changes today.

Components of Cardiovascular Screening

Cardiovascular screening contains several connected parts. An ECG lead forms a component of an MCG recording, and the electrical signals it captures reflect heart function. Microvascular function forms a component of coronary health that structural imaging misses. hs-CRP, homocysteine and Lp(a) form components of a cardiovascular risk panel, measuring inflammation and inherited risk. A calcium score forms a component of structural coronary assessment. Blood pressure, blood sugar and family history form the foundation of overall risk. Combining these parts gives a fuller view than any single test.

Summary

The MCG heart scan is an FDA-cleared, 10-minute resting test that analyzes the heart's electrical signals for early signs of ischemia and heart dysfunction, without needles, radiation or exercise. It complements the EKG, stress testing, echocardiography and calcium scoring, and pairs with blood markers such as Lp(a), ApoB, homocysteine and hs-CRP. Heart disease often develops without symptoms, normal cholesterol does not rule it out, and menopause accelerates risk in women. The MCG Heart Scan offers that early look, followed by a results review with Dr. McCully.

Sources

• Centers for Disease Control and Prevention. Heart Disease Facts.
• Centers for Disease Control and Prevention. About Women and Heart Disease.
• El Khoudary SR et al. Menopause transition and cardiovascular disease risk: implications for timing of early prevention. A scientific statement from the American Heart Association. Circulation, 2020.
• Coronary microvascular dysfunction: what clinicians and investigators should know.
• U.S. Preventive Services Task Force. Cardiovascular disease risk: screening with electrocardiography. Final recommendation statement, 2018.
• Grundy SM et al. 2018 AHA/ACC guideline on the management of blood cholesterol. Circulation, 2019.
• Koschinsky ML et al. A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice. Journal of Clinical Lipidology, 2024.
• Martí-Carvajal AJ et al. Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews, 2017.
• Sachdeva A et al. Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get With The Guidelines. American Heart Journal, 2009.
• Strobeck JE, Mangieri A, Rainford N. A paired-comparison of the MultiFunction CardioGram (MCG) and sestamibi SPECT myocardial perfusion imaging to quantitative coronary angiography for the detection of relevant coronary artery obstruction (≥70%). International Journal of Medical Sciences, 2011.
• U.S. Food and Drug Administration. 510(k) premarket notification database, Premier Heart, 2000.

Free tool: Heart and Metabolic Risk Scorecard →